Difference between revisions of "Postmortem Chemotherapy"
From Gomerpedia
(Created page with "Recently approved by the FDA, '''postmortem chemotherapy''' is a radical form of medical treatment in which "a ray of hope is offered to those who are no longer with us."<...") |
|||
Line 1: | Line 1: | ||
− | Recently approved by the [[FDA]], '''postmortem chemotherapy''' is a radical form of medical treatment in which "a ray of hope is offered to those who are no longer with us. | + | Recently approved by the [[FDA]], '''postmortem chemotherapy''' is a radical form of medical treatment in which "a ray of hope is offered to those who are no longer with us" by administering chemotherapy anywhere within 1 month and up to 5 years after a patient's death.<ref>[http://gomerblog.com/2017/01/fda-approves-groundbreaking-postmortem-chemotherapy-protocol/ FDA Approves Groundbreaking Postmortem Chemotherapy Protocol]</ref> |
+ | |||
+ | |||
+ | '''Patient Selection''' | ||
+ | ---- | ||
+ | Candidates for '''postmortem chemotherapy''' most undergo a rigorous selection process during which they must prove their lack of functional status but are clearly still "a fighter."<ref>[http://gomerblog.com/2016/11/hospital-morgue/ Hospital Morgue Morning Rounds Initiated After Family Insists Patient “is a Fighter”]</ref> | ||
+ | |||
+ | |||
+ | '''Does It Work?''' | ||
+ | ---- | ||
+ | If '''postmortem chemotherapy''' continues its current rate of success, then by the end of 2017 100% of decreased patients should remain dead. | ||
Revision as of 17:20, 28 January 2017
Recently approved by the FDA, postmortem chemotherapy is a radical form of medical treatment in which "a ray of hope is offered to those who are no longer with us" by administering chemotherapy anywhere within 1 month and up to 5 years after a patient's death.[1]
Patient Selection
Candidates for postmortem chemotherapy most undergo a rigorous selection process during which they must prove their lack of functional status but are clearly still "a fighter."[2]
Does It Work?
If postmortem chemotherapy continues its current rate of success, then by the end of 2017 100% of decreased patients should remain dead.
References